Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gregory

Showing results (821-830 of 1,034) with videos related to

Pageof 104
Sort By:
The New England Journal of Medicine|July 10, 2009
Hearing improvement after bevacizumab in patients with neurofibromatosis type 2Scott R Plotkin, Anat O Stemmer-Rachamimov, Fred G Barker, et al.
Optics Express|February 8, 2013
Magnetic control of a meta-moleculeGavin B G Stenning, Graham J Bowden, Lewis C Maple, et al.
Prostaglandins & Other Lipid Mediators|May 16, 2018
Prominent release of lipoxygenase generated mediators in a murine house dust mite-induced asthma modelJohan Kolmert, Sergio Piñeiro-Hermida, Mats Hamberg, et al.
Journal of Dental Research|March 8, 2023
A Salivary Gland Resident Macrophage Subset Regulating Radiation ResponsesQ Zhao, S Pan, L Zhang, et al.
Plos One|February 25, 2012
Genes that influence swarming motility and biofilm formation in Variovorax paradoxus EPSMichael J Pehl, William David Jamieson, Karen Kong, et al.
British Journal of Cancer|March 12, 2022
Morpholino-driven blockade of Dkk-1 in osteosarcoma inhibits bone damage and tumour expansion by multiple mechanismsSimin Pan, Michael Cesarek, Carla Godoy, et al.
The Journal of Cell Biology|March 17, 2004
In vivo kinetics of Cajal body componentsMiroslav Dundr, Michael D Hebert, Tatiana S Karpova, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Temperature signals drive grass secondary cell wall thickeningGreg A Gregory, Joshua H Coomey, Bahman Khahani, et al.
Neuro-Oncology|March 29, 2018
Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686Jerrold L Boxerman, Zheng Zhang, Yair Safriel, et al.
Neuro-Oncology|June 22, 2013
Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader StudyJerrold L Boxerman, Zheng Zhang, Yair Safriel, et al.
Pageof 104

Showing results (821-830 of 1,034) with videos related to

Sort By:
Pageof 104
The New England Journal of Medicine|July 10, 2009
Hearing improvement after bevacizumab in patients with neurofibromatosis type 2Scott R Plotkin, Anat O Stemmer-Rachamimov, Fred G Barker, et al.
Optics Express|February 8, 2013
Magnetic control of a meta-moleculeGavin B G Stenning, Graham J Bowden, Lewis C Maple, et al.
Prostaglandins & Other Lipid Mediators|May 16, 2018
Prominent release of lipoxygenase generated mediators in a murine house dust mite-induced asthma modelJohan Kolmert, Sergio Piñeiro-Hermida, Mats Hamberg, et al.
Journal of Dental Research|March 8, 2023
A Salivary Gland Resident Macrophage Subset Regulating Radiation ResponsesQ Zhao, S Pan, L Zhang, et al.
Plos One|February 25, 2012
Genes that influence swarming motility and biofilm formation in Variovorax paradoxus EPSMichael J Pehl, William David Jamieson, Karen Kong, et al.
British Journal of Cancer|March 12, 2022
Morpholino-driven blockade of Dkk-1 in osteosarcoma inhibits bone damage and tumour expansion by multiple mechanismsSimin Pan, Michael Cesarek, Carla Godoy, et al.
The Journal of Cell Biology|March 17, 2004
In vivo kinetics of Cajal body componentsMiroslav Dundr, Michael D Hebert, Tatiana S Karpova, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Temperature signals drive grass secondary cell wall thickeningGreg A Gregory, Joshua H Coomey, Bahman Khahani, et al.
Neuro-Oncology|March 29, 2018
Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686Jerrold L Boxerman, Zheng Zhang, Yair Safriel, et al.
Neuro-Oncology|June 22, 2013
Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader StudyJerrold L Boxerman, Zheng Zhang, Yair Safriel, et al.
Pageof 104